Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw
- PMID: 30938596
- PMCID: PMC6728448
- DOI: 10.1177/2380084418770662
Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw
Abstract
Knowledge Transfer Statement: This article discusses the proceedings of the conference organized by the Task Force on Design and Analysis in Oral Health Research on the understanding of the translational evidence on the etiology and pathogenesis of medication-related osteonecrosis of the jaw as well as the clinical protocols on patient management.
Keywords: MRONJ pathophysiology; MRONJ therapy; antiresorptive; bisphosphonates; microbiome; osteonecrosis of the jaws.
Conflict of interest statement
S. Tetradis and T. Aghaloo have served as paid consultants for and have received grant support from Amgen Inc. The authors declare no other potential conflicts of interest with respect to the authorship and/or publication of this article.
References
-
- Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, et al. 2015. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 30(1):3–23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
